Summit Therapeutics (SMMT) Amortizatization of Intangibles (2023 - 2026)

Summit Therapeutics (SMMT) has reported Amortizatization of Intangibles for 4 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.

• Quarterly Amortizatization of Intangibles rose 190.22% year-over-year to $3.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $10.2 million (up 123.85% YoY) and the FY2025 annual result came in at $7.0 million, up 171.97% from the prior year.
• Amortizatization of Intangibles fell to $3.0 million in Q2 2026 per SMMT's latest filing, from $4.2 million in the prior quarter.
• Over the last five years, Amortizatization of Intangibles for SMMT reached as high as $4.2 million in Q1 2026 and fell as low as -$2.4 million in Q4 2024.
• A 4-year average of $1.6 million and a median of $2.3 million in 2023 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2024 — Amortizatization of Intangibles slumped 1229.81% — and 2025, when it soared 637.81%.
• Year by year, Amortizatization of Intangibles stood at $208000.0 in 2023, then sank by 1229.81% to -$2.4 million in 2024, then jumped by 228.38% to $3.0 million in 2025, then fell by 1.59% to $3.0 million in 2026.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $3.0 million, $4.2 million, and $3.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.